Cargando…
Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer Cells
Breast cancer remains the major cause of cancer-induced morbidity and mortality in women. Among the different molecular subtypes, luminal tumors yet considered of good prognosis often develop acquired resistance to endocrine therapy. Recently, misregulation of ERα36 was reported to play a crucial ro...
Autores principales: | Thiebaut, Charlène, Chesnel, Amand, Merlin, Jean-Louis, Chesnel, Maelle, Leroux, Agnès, Harlé, Alexandre, Dumond, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600239/ https://www.ncbi.nlm.nih.gov/pubmed/31146345 http://dx.doi.org/10.3390/ijms20112637 |
Ejemplares similares
-
The Role of ERα36 in Development and Tumor Malignancy
por: Thiebaut, Charlène, et al.
Publicado: (2020) -
Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression
por: Thiebaut, Charlène, et al.
Publicado: (2017) -
From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression
por: Chamard-Jovenin, Clémence, et al.
Publicado: (2015) -
An Alkylphenol Mix Promotes Seminoma Derived Cell Proliferation through an ERalpha36-Mediated Mechanism
por: Ajj, Hussein, et al.
Publicado: (2013) -
Lifelong testicular differentiation in Pleurodeles waltl (Amphibia, Caudata)
por: Flament, Stéphane, et al.
Publicado: (2009)